Swallowing Initiation Training for Head and Neck Cancer-Related Swallowing Disorders
Trial Summary
What is the purpose of this trial?
This trial tests a new method that teaches head and neck cancer survivors to swallow while exhaling. This approach aims to make swallowing safer and more efficient for those who have trouble swallowing after their cancer treatment.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Swallow Practice, Respiratory-Swallow Phase Training, and Swallowing Initiation During Expiration for head and neck cancer-related swallowing disorders?
Research shows that training to coordinate swallowing with breathing can improve swallowing safety and efficiency in head and neck cancer patients. This approach helps protect the airway and enhances swallowing function, which is crucial for patients with swallowing difficulties after cancer treatment.12345
Is Swallowing Initiation Training safe for humans?
The research on swallowing exercises and respiratory-swallow training for head and neck cancer patients suggests that these interventions are generally safe, with no significant safety concerns reported in the studies. However, adherence to the exercises can be challenging, and some participants experienced fatigue.12467
How is the Swallowing Initiation Training for head and neck cancer-related swallowing disorders different from other treatments?
This treatment is unique because it focuses on retraining the coordination between breathing and swallowing, specifically teaching patients to swallow during the exhalation phase of breathing, which can improve swallowing safety and efficiency. Unlike traditional therapies that target only the muscles involved in swallowing, this approach aims to restore the natural timing between breathing and swallowing, offering potential benefits for patients with chronic swallowing difficulties after head and neck cancer treatment.12345
Research Team
Bonnie Martin-Harris, PhD
Principal Investigator
Northwestern Memorial Hospital
Eligibility Criteria
This trial is for English-speaking adults who've had head and neck cancer, are three months post-treatment, can swallow some liquids, and have a certain level of swallowing difficulty. They must pass a cognitive test and not have severe lung disease or allergies to materials used in the study. Pregnant individuals or those with recurrent cancer, drug abuse history, neurological disorders, feeding tubes, or tracheostomy tubes cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive respiratory-swallow phase training to improve swallowing safety and efficiency
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Swallow Practice
- Training Swallowing Initiation During Expiration
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Northwestern Memorial Hospital
Collaborator